The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...

At an online roundtable event hosted by CHEManager, a group of industry experts discussed the reasons why microreaction technology (MRT) has not achieved the status for...

Pfizer has agreed to buy privately held, clinical-stage biopharma ReViral for up to $525 million, including upfront and development milestones. ReViral is focused on...

There can be no doubt that we are living through transformational times, driven by unprecedented disruptive events and the overall trends in society and markets.

British drugs giant GlaxoSmithKline (GSK) is buying US cancer treatment developer Sierra Oncology for £1.5 billion in a deal observers see as designed to fend off...

With all European energy discussions now focusing on dramatic cuts in supplies of Russian gas, Dow Chemical is taking an undisclosed minority stake in an import terminal...

Tecnimont, part of Italian engineering and technology group Maire Tecnimont, has won two contracts in the US from the same company. The contracts, worth $415 million in...